Upstream Regulators of Fibroblast Growth Factor 23 [PDF]
Frontiers in Endocrinology, 2021 Fibroblast growth factor 23 (FGF23) has been described as an important regulator of mineral homeostasis, but has lately also been linked to iron deficiency, inflammation, and erythropoiesis. FGF23 is essential for the maintenance of phosphate homeostasis
Danielle M. A. Ratsma +2 more
doaj +3 more sources
Physiological Actions of Fibroblast Growth Factor-23 [PDF]
Frontiers in Endocrinology, 2018 Fibroblast growth factor-23 (FGF23) is a bone-derived hormone suppressing phosphate reabsorption and vitamin D hormone synthesis in the kidney. At physiological concentrations of the hormone, the endocrine actions of FGF23 in the kidney are αKlotho ...
Reinhold G. Erben
doaj +3 more sources
Fibroblast Growth Factor-23—A Potential Uremic Toxin [PDF]
Toxins, 2016 Fibroblast growth factor-23 (FGF23) is a circulating member of the FGF family produced mainly by the osteocytes and osteoblasts that can act as a hormone.
Piotr Kuczera +2 more
doaj +4 more sources
Phosphate and fibroblast growth factor 23 in diabetes [PDF]
Clinical Science, 2021 AbstractDiabetes is associated with a strongly elevated risk of cardiovascular disease, which is even more pronounced in patients with diabetic nephropathy. Currently available guideline-based efforts to correct traditional risk factors are only partly able to attenuate this risk, underlining the urge to identify novel treatment targets.
Amarens van der Vaart +4 more
openalex +3 more sources
Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population [PDF]
Journal of Cachexia, Sarcopenia and MuscleBackground Sarcopenia is defined as the loss of muscle mass, strength, and/or performance. It is strongly associated with all‐cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially ...
Limy Wong +5 more
doaj +2 more sources
Il Fibroblast Growth Factor-23 (FGF-23)
Giornale di Clinica Nefrologia e Dialisi, 2018 Negli ultimi due decenni, l'identificazione delle proprietà biologiche del Fibroblast Growth Factor 23 (FGF23) ha notevolmente ampliato le conoscenze sulla regolazione endocrina e paracrina dell'omeostasi dei fosfati e sulle relazioni intercorrenti tra ...
D. Rendina +4 more
doaj +4 more sources
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia [PDF]
Endocrinology and MetabolismFibroblast growth factor 23 (FGF23) is a pivotal humoral factor for the regulation of serum phosphate levels and was first identified in patients with autosomal dominant hypophosphatemic rickets and tumor-induced osteomalacia (TIO), the most common form ...
Nobuaki Ito, Naoko Hidaka, Hajime Kato
doaj +2 more sources
Burosumab treatment for fibroblast growth factor-23-associated hypophosphatemia in an adult patient with severe fibrous dysplasia in McCune-Albright syndrome: case report and review of the literature. [PDF]
JBMR PlusStelmachowska-Banaś M +4 more
europepmc +2 more sources
Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy. [PDF]
NPJ Metab Health DisLatic N +13 more
europepmc +3 more sources